Synaptic Density PET tracer evaluation

What is the purpose of this trial?

You are invited to take part in a research study designed to evaluate the number of synapses, tau pathology, glucose metabolism, beta amyloid accumulation in the brain in Alzheimer’s disease and in healthy aging using positron emission tomography (PET) scans. In this way, we hope to better understand how the brain may change in people with Alzheimer’s disease.  You are being asked to take part because you are between 55-90 years of age and may have dementia due to Alzheimer’s disease. 

Participation Guidelines

Ages: 55 - 90 years

Gender: Both

Eli Lilly and Company

Start Date: 05/10/2017

End Date: 05/10/2019

Last Updated: 05/04/2018

Study HIC#: 2000020626

Get Involved

For more information about this study, contact:
Joanna Harris
+1 203-764-8100

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Ming-Kai Chen

Principal Investigator